NR
Naveen R
Sanjay Gandhi Post Graduate Institute of Medical Sciences, SRM University, Madras Medical College, Stanley Medical College
Research areas: Medicine · Rheumatology · Inflammatory Myopathies and Dermatomyositis · Systemic Lupus Erythematosus Research · Systemic Sclerosis and Related Diseases
Employment
-
Sanjay Gandhi Post Graduate Institute of Medical Sciences Assistant Professor2021 - Present
-
SRM University Senior Resident/ IMCU Assistant2017 - 2018
Education
- 2018 - Present
- 2014 - 2017
- 2007 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (52)
- Discordance in Patient and Physician's Perception of Disease Activity Among Idiopathic Inflammatory Myopathy Patients: Insights From the COVAD Study Save
- Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study Save
- Reduced Health‐Related Quality of Life in Patients With Systemic Sclerosis: A Cross‐Sectional Analysis of PROMIS Global Health Data From the International COVAD‐2 e‐Survey Save
- Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort Save
- COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study Save
- Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group Save
- Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study Save
- Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys Save
- Flares of autoimmune rheumatic disease following COVID‐19 infection: Observations from the COVAD study Save
- Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study Save
- COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group Save
- Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys Save
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys Save
- Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey Save
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study Save
- Predictors of long-term functional outcomes of juvenile idiopathic arthritis–enthesitis-related arthritis: a single centre experience Save
- COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis Save
- Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study Save
- Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study Save
- High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey Save